Skip to main content

Ventyx Biosciences, Inc.

VTYXDelisted Mar 4, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001851194

Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding Ventyx Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of VTYX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1261117−8
Shares59.0M1.80K57.3M−1.75M (−3.0%)
Value$323.8M$9.00K$132.3M−$191.6M (−59.2%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to VTYX in Q2 2024
InstitutionSharesValue% of portfolio
Vestal Point Capital, LP1,315,000$3.04M0.23%
Jacobs Levy Equity Management, Inc475,726$1.10M0.00%
Woodline Partners LP379,175$875.9K0.01%
Acadian Asset Management LLC263,565$608.0K0.00%
Graham Capital Management, L.P.220,929$510.3K0.02%
Jump Financial, LLC105,836$244.5K0.00%
Verition Fund Management LLC79,532$183.7K0.00%
Sherbrooke Park Advisers LLC75,890$175.3K0.03%
Point72 (DIFC) Ltd66,615$153.9K0.01%
AQR Capital Management LLC56,551$130.6K0.00%
Dark Forest Capital Management LP38,126$88.1K0.02%
Corebridge Financial, Inc.32,696$75.5K0.00%
Dynamic Technology Lab Private Ltd29,947$69.0K0.01%
American Century Companies Inc25,883$59.8K0.00%
Point72 Asia (Singapore) Pte. Ltd.25,303$58.5K0.01%
Mirae Asset Global ETFs Holdings Ltd.24,405$56.4K0.00%
SG Americas Securities, LLC13,878$32.0K0.00%
Advisor Group Holdings, Inc.804$1.86K0.00%
Optiver Holding B.V.498$1.15K0.00%
Rothschild Investment LLC25$580.00%
Capital Advisors, Ltd. LLC15$00.00%

Sold out (29)

Institutions that held Ventyx Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (1)

Institutions that held Ventyx Biosciences, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VTYX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cutler Group LP1,800$9.00K